“driving with dementia”的搜索结果，显示 41-50 项，共有 313 项

1. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla. To further investigate biomarkers in CSF as possible predictors for mild cognitive impairment and dementia. A study to ...

2. 血管性痴呆- 诊断与治疗- 妙佑医疗国际

   O'Brien JT, et al. Vascular dementia. The Lancet. 2015;386:1698. Dementia: Hope through research. National Institute of Neurological Disorders and Stroke ...

3. 路易体失智症- 在 Mayo Clinic 治疗 - 妙佑医疗国际

   Researchers create 'mini brains' to model Lewy body dementia and pinpoint treatments Oct. 09, 2024, 03:00 p.m. CDT. 产品与服务. 书籍：《失智症患者的日常照护》 ...

4. 失智症 - 医生与科室 - 妙佑医疗国际

   一组病因众多的症状，影响记忆、思维和社交能力。部分症状是可逆的。

5. 临床试验- 精神病科和心理科- 妙佑医疗国际

   The goal of this study is to gain a better understanding of the status of advanced care planning among caregivers of patients with dementia and examine how this ...

6. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

7. 边缘系统为主的年龄相关性TDP-43 脑病（LATE） - 妙佑医疗国际

   ... Alzheimer's Disease Research Center autopsy cohort. Alzheimer's and Dementia. 2022; doi:10.1002/alz.12639. Memory, forgetfulness, and aging: What's normal ...

8. 失智症- 诊断与治疗- 妙佑医疗国际

   Cummings J, et al. Alzheimer's disease drug development pipeline: 2022. Alzheimer's and Dementia. 2022; doi:10.1002/trc2.12295. Oxybutynin oral. Facts ...

9. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

10. 神经科- 临床试验- 妙佑医疗国际

    ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...